HVO Hvivo Plc

TIDMVENN

RNS Number : 3865Y

Venn Life Sciences Holdings PLC

21 February 2013

Venn Life Sciences Holdings Plc

("Venn" or the "Company")

Director's Dealing

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces that Tony Richardson, a director, has transferred 60,000 ordinary shares from his own name and 72,212 ordinary shares from Coolford Limited (a company jointly owned by Tony Richardson and his wife) into his pension fund. The shares were transferred at a price of 33p

There has been no change in Tony Richardson's beneficial shareholding in Venn as a result of these transactions.

 
 Enquiries: 
Venn Life Sciences Holdings Plc 
Tony Richardson, Chief Executive      Tel: +353 154 99 341 
 Officer 
Paul Foulger, Finance Director        Tel: 020 7245 1100 
 
Zeus Capital (Nominated Adviser and 
 Broker) 
Ross Andrews/Andrew Jones (Corporate  Tel: 0161 831 1512 
 Finance) 
John Goold (Institutional Sales)      Tel: 020 7016 8925 
 
Walbrook PR Ltd                       Tel: 020 7933 8787 or Mob: 
                                       07980 541 893 
Paul McManus                          paul.mcmanus@walbrookpr.com 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSLIFSAFRILFIV

Hvivo (LSE:HVO)
Historical Stock Chart
From Jun 2024 to Jul 2024

Hvivo (LSE:HVO)
Historical Stock Chart
From Jul 2023 to Jul 2024